COVID-19 vaccination: invitations being sent to risk groups From 27 August 2024 on, the first people will receive an invitation for COVID-19 vaccination. RIVM will send the invitations to people aged 60 years and older.
Fewer whooping cough antibodies if vaccination occurs before 24th week of pregnancy Babies develop fewer antibodies against pertussis (whooping cough) if the mother is given the pertussis vaccine before the 24th week of pregnancy. These findings are from a multi-year study carried out by RIVM among preterm and full-term babies and their mothers.
New COVID-19 vaccination round for risk groups this autumn The new COVID-19 vaccination round will start on 16 September 2024. For people who are at higher risk, the COVID-19 vaccination offers more effective protection against hospital admission or death due to COVID-19.
Metals from Essure sterilisation coils unlikely to be harmful to health Essure is an implant used for female sterilisation. Like many other implants, such as hip implants and stents, this implant is made of metal. It is normal for such implants to release metal particles. Essure is a small implant.
New research portal for people with post-COVID Starting today, people with post-COVID can sign up to take part in scientific research. They can register through the national portal at postcovidonderzoek.nl, which is part of the Post-COVID Network Netherlands.
MEBI: risk of serious health complaints from Rebound HRD® inguinal hernia mesh The Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI), which is part of RIVM, has received a report about Rebound HRD® (Hernia Repair Device), an inguinal hernia mesh.
Vaccination coverage of babies and toddlers remained about the same, but decreased among older children The percentage of babies and toddlers that were vaccinated in the framework of the National Immunisation Programme remained about the same compared to last year. In children aged 9 years and older, vaccination coverage continued to decrease for most of the national childhood immunisations. iStock
Well-being should be considered from the start when formulating policy during pandemic, health emergency or other crisis Monitoring well-being from the outset and throughout the duration of a pandemic, health emergency or other crisis provides helpful input in making policy choices.
Study on the effectiveness of COVID-19 measures in the Netherlands The measures implemented in the Netherlands during the COVID-19 crisis were effective against the spread of the SARS-CoV-2 virus. This is the outcome of a study conducted by RIVM.
PhD research shows: ‘repeating vaccination promotes whooping cough resistance’ Repeating vaccination promotes whooping cough resistance. This is evidenced by the PhD research conducted by Pauline Versteegen. She researched post-vaccination immunity to whooping cough in age groups from 7 to 70 years. On Tuesday 28 May, she was awarded her doctoral degree at Utrecht University.